[
  {
    "ts": null,
    "headline": "REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit",
    "summary": "NEW YORK, Jan. 27, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Regeneron...",
    "url": "https://finnhub.io/api/news?id=9530d8e57da18c4c6078d88c0f70b9d48f74daf83ce0e11add1bfb938ca9535e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737997685,
      "headline": "REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit",
      "id": 132481670,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "NEW YORK, Jan. 27, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Regeneron...",
      "url": "https://finnhub.io/api/news?id=9530d8e57da18c4c6078d88c0f70b9d48f74daf83ce0e11add1bfb938ca9535e"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains",
    "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=26666ae6f979cb26892a45043e2f7981efc784707d2177d32f6da2ad1846d5fb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737996180,
      "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains",
      "id": 132526853,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=26666ae6f979cb26892a45043e2f7981efc784707d2177d32f6da2ad1846d5fb"
    }
  },
  {
    "ts": null,
    "headline": "REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm",
    "summary": "LOS ANGELES, Jan. 27, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ...",
    "url": "https://finnhub.io/api/news?id=9c18d3d4ab73bb021cb6917d3ca2093eca4e27f5ab672ddb7a05e6e30be5e64c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737974465,
      "headline": "REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm",
      "id": 132479859,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "LOS ANGELES, Jan. 27, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ...",
      "url": "https://finnhub.io/api/news?id=9c18d3d4ab73bb021cb6917d3ca2093eca4e27f5ab672ddb7a05e6e30be5e64c"
    }
  },
  {
    "ts": null,
    "headline": "Contact The Gross Law Firm by March 10, 2025 Deadline to Join Class Action Against Regeneron Pharmaceuticals, Inc.(REGN)",
    "summary": "NEW YORK, Jan. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. . ...",
    "url": "https://finnhub.io/api/news?id=72af16e1e7ed28365752875a71440ac2a930ee4b5aed31cfeb1d7e95ce87a64e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737956780,
      "headline": "Contact The Gross Law Firm by March 10, 2025 Deadline to Join Class Action Against Regeneron Pharmaceuticals, Inc.(REGN)",
      "id": 132478245,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "NEW YORK, Jan. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. . ...",
      "url": "https://finnhub.io/api/news?id=72af16e1e7ed28365752875a71440ac2a930ee4b5aed31cfeb1d7e95ce87a64e"
    }
  }
]